SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-003097
Filing Date
2021-11-04
Accepted
2021-11-04 16:44:03
Documents
68
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q gbt-20210930.htm   iXBRL 10-Q 3205410
2 EX-10.1 gbt-ex10_1.htm EX-10.1 49218
3 EX-31.1 gbt-ex31_1.htm EX-31.1 15705
4 EX-31.2 gbt-ex31_2.htm EX-31.2 15676
5 EX-32.1 gbt-ex32_1.htm EX-32.1 13291
6 GRAPHIC img172930187_0.jpg GRAPHIC 3220
  Complete submission text file 0000950170-21-003097.txt   9713270

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gbt-20210930_pre.xml EX-101.PRE 327720
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gbt-20210930_def.xml EX-101.DEF 186160
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gbt-20210930.xsd EX-101.SCH 44335
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gbt-20210930_lab.xml EX-101.LAB 424005
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gbt-20210930_cal.xml EX-101.CAL 53985
12 EXTRACTED XBRL INSTANCE DOCUMENT gbt-20210930_htm.xml XML 1846612
Mailing Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37539 | Film No.: 211380587
SIC: 2834 Pharmaceutical Preparations